Lisa Anson

Chief Executive Officer

Experienced General Manager, former President of AstraZeneca UK and has significant leadership experience in pharmaceuticals

Dr. Richard Armer

Scientific Adviser

Experienced drug discovery executive, ex Pfizer, Organon, Ardana, Oxagen, Lectus Therapeutics

Dr. Inder Bhamra

VP, Head of Chemistry and DMPK

Experienced medicinal chemist with leadership responsibilities for small molecule drug discovery and preclinical development programmes

Andrew Booth

Group Financial Controller

Experienced Financial Controller of listed companies

Peter Collum

Chief Financial Officer

Experienced biopharma finance and strategy executive, previously CFO and CBO of Pharnext SA

Dr. Nicolas Guisot

VP, Head of Development Science

Experienced drug hunter with strong expertise in small molecule drug discovery and early clinical development. Inventor of JaypircaTM (Pirtobrutinib, RXC005)

Dr. Cliff Jones

Chief Innovation Officer

Experienced medicinal chemist with broad drug discovery expertise, previously with AstraZeneca in the UK and France

Helen McKeever

Head of Nonclinical Development

Experienced program manager with over 25 years experience in nonclinical and early clinical drug development in biotech and contract research

Dr. James Mead

Chief Operating Officer

Previously CFO of AstraZeneca Netherlands, with wide sector experience

Caitlin Pearson

Head of Communications

A strategic communications specialist with AIM-listed biotech experience

Dr. Caroline Phillips

Chief Scientific Officer

Extensive experience in drug discovery and early clinical development

Claire Solk

Chief Legal Officer and Company Secretary

Legal counsel with extensive life sciences experience

Craig Tilston

Craig Tilston

Head of Development Operations

Experienced drug developer ex. AstraZeneca and Pfizer. Closely involved with the development of a number of successful compounds including Tagrisso™, Lipitor™, Champix™ and Viagra™

Dr. Helen Timmis

Interim Chief Medical Officer

Clinical physician with extensive experience in drug development

Dr. Simon Woodcock

VP, Head of Biology

Cancer biology expert with drug discovery and early clinical development experience, previously with AstraZeneca and CRUK.